CICLOPS Immune Checkpoint Inhibitors Neurotoxicity: Long-term Outcomes, Predictors, and Survival.

NCT05942872 · clinicaltrials.gov ↗

COMPLETED

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Paraneoplastic Syndromes

Interventions

OTHER: This is a non-interventional study. We will collect clinical data exclusively, and will do so by reviewing all available patients clinical records.

Sponsor

Hospices Civils de Lyon